Introduction
============

Telomeres consist of double-stranded DNA (dsDNA) and single-stranded DNA (ssDNA), bound by dsDNA- and ssDNA-binding proteins ([@b4]; [@b33]). This nucleoprotein 'cap\' has at least two functions: to shield the telomeric DNA from stimulating the DNA damage response (DDR) and to regulate elongation of the telomere by telomerase. In human senescent cells, dysfunctional telomeres induce a sustained DDR ([@b16]). In both budding yeast and mice, nuclease activities that attack dysfunctional telomeres contribute to telomere-driven senescence ([@b39]; [@b54]). Therefore, understanding the regulation of nuclease activities at dysfunctional telomeres in yeast is likely to be informative about similar processes occurring at mammalian telomeres and the human ageing process.

dsDNA-binding proteins and accessory factors are required at both human telomeres (TRF1, TRF2, TIN2, TPP1, RAP1) and budding yeast telomeres (Rap1, Rif1, Rif2) to prevent DDRs ([@b71]; [@b17]; [@b10]; [@b37]; [@b5]; [@b68]). In budding yeast, telomeric ssDNA is bound by Cdc13 with accessory proteins Stn1 and Ten1, whereas in human cells, it is bound by POT1 ([@b17]; [@b21]). Cdc13--Stn1--Ten1 forms an evolutionarily conserved complex (the CST complex) that has telomeric roles in most organisms studied so far ([@b43]; [@b59]). POT1 binds telomeric ssDNA and is connected to the dsDNA-binding proteins of the telomere cap by TPP1 and TIN2 ([@b18]). Inactivation of POT1 or Cdc13 induces 'telomere uncapping\' and has similar consequences---initiation of a DDR and resection of the telomeric DNA by nuclease activities ([@b22]; [@b3]; [@b49]).

The response to telomere uncapping is readily studied in budding yeast by inactivation of Cdc13 using the thermosensitive allele *cdc13-1* ([@b22]). Following Cdc13 inactivation, a potent DDR is initiated; telomeric DNA is resected by nucleases, which degrade the AC (5′) strand to generate extensive TG (3′) ssDNA that stimulates activation of the DNA damage checkpoint, in a manner analogous to that at DNA double-strand breaks (DSBs) ([Figure 1A](#f1){ref-type="fig"}) ([@b22]; [@b34]; [@b69]). There is relatively little understanding of the nuclease activities responsible for generating ssDNA at uncapped telomeres ([@b75]). In contrast, there has been much recent progress identifying nuclease activities that function at DSBs ([@b26]; [@b41]; [@b74]).

Exo1 is the only nuclease known to generate ssDNA at uncapped telomeres in budding yeast ([@b38]). Exo1 is a 5′ to 3′ dsDNA exonuclease involved in DSB resection and in mismatch repair ([@b63]; [@b26]; [@b41]; [@b74]). In the absence of Exo1, ssDNA is still generated following Cdc13 inactivation, demonstrating that other nuclease activities must also function at uncapped telomeres. The determinant(s) of this Exo1-independent ssDNA generation have not so far been identified, but at least two hypothetical nuclease activities have been proposed (ExoX and ExoY) ([@b75]).

We sought to identify additional nuclease activities functioning at uncapped telomeres following inactivation of Cdc13. Bioinformatic analysis of genetic interactions found the helicase Pif1 to be a candidate for contributing to nuclease activity. Consistent with this hypothesis, we found that Pif1 and Exo1 are required for different nuclease activities that generate ssDNA and activate the DNA damage checkpoint following Cdc13 inactivation. Furthermore, deletion of both *PIF1* and *EXO1* permits yeast cells to tolerate complete loss of the essential telomere capping protein Cdc13.

Results
=======

PIF1 and EXO1 define parallel pathways that inhibit growth of cdc13-1 mutants
-----------------------------------------------------------------------------

To identify potential nuclease(s) active in *cdc13-1* mutants, we reasoned that genes responsible for such activities would interact with similar genes to those that *EXO1* interacts with. We used the BioGRID database to create a ranked list of genes that had similar genetic interactions to *EXO1* ([Figure 1B](#f1){ref-type="fig"}) ([@b58]). Of these, 9/19 affected *cdc13-1* growth or telomere length. Deletion of *EXO1* suppresses *cdc13-1* growth defects, so we focussed on those genes that also suppressed *cdc13-1* growth defects. By these criteria, two previously characterized checkpoint genes (*RAD9* and *RAD24*) and the helicase-encoding *PIF1* behaved similarly to *EXO1* ([Figure 1B](#f1){ref-type="fig"}). Rad9 and Rad24 do indeed regulate nuclease activities at uncapped telomeres and are required for checkpoint activation ([@b22]; [@b34]; [@b75]). Pif1 has been shown to inhibit growth of *cdc13-1* mutants ([@b19]), whereas overexpression of Pif1 has been shown to enhance growth defects seen in *cdc13-1* mutants, but the contribution of Pif1 to the nuclease activity and checkpoint activation in *cdc13-1* mutants had not been assessed ([@b67]; [@b12]).

Pif1 is a helicase with both mitochondrial and nuclear functions ([@b65]; [@b55]). In the nucleus, Pif1 has been implicated in negative regulation of telomerase, generation of long flaps during Okazaki fragment processing, unwinding of G-quadruplexes and disassembly of stalled replication forks ([@b73]; [@b8]; [@b9]; [@b12]; [@b24]; [@b36]; [@b48]; [@b52]; [@b72]). To test the hypothesis that Pif1 contributes to a nuclease activity at uncapped telomeres in *cdc13-1* mutants, we compared the effects of Pif1 and Exo1 on cell growth after Cdc13-1 inactivation. At the permissive temperature (23°C), Cdc13-1 is functional and efficiently caps the telomeres, permitting growth of *cdc13-1* mutants. At the non-permissive temperature (36°C), Cdc13-1 is completely defective and *cdc13-1* mutants are unable to grow ([Figure 1A and C](#f1){ref-type="fig"}). At semi-permissive temperatures (25--29°C), moderate Cdc13-1 inactivation occurs and growth of *cdc13-1* mutants is inhibited ([Figure 1C](#f1){ref-type="fig"}). As previously reported, *cdc13-1 pif1*Δ and *cdc13-1 exo1*Δ mutants are able to grow at 27°C, whereas *cdc13-1* mutants are not ([Figure 1C](#f1){ref-type="fig"}) ([@b75]; [@b19]). These effects on growth are consistent with the hypothesis that Pif1, like Exo1, contributes to nuclease activity at uncapped telomeres.

Pif1 and Exo1 inhibit growth of *cdc13-1* mutants, possibly by contributing to nuclease activity at uncapped telomeres. To test whether the two proteins worked in the same pathway/complex or in different pathways, we examined the effect Pif1 on growth of *cdc13-1 exo1*Δ mutants. *cdc13-1 exo1*Δ mutants were unable to grow at 30°C, whereas *cdc13-1 exo1*Δ *pif1*Δ mutants were able to grow at 30 and 36°C ([Figure 1C](#f1){ref-type="fig"}). Remarkably, at 36°C, the growth of *cdc13-1 exo1*Δ *pif1*Δ mutants was barely distinguishable from that of *CDC13*^+^ *exo1*Δ *pif1*Δ mutants ([Supplementary Figure S1A](#S1){ref-type="supplementary-material"}). We confirmed that this effect was due to the *pif1*Δ and *exo1*Δ mutations and not due to second site suppressors arising in our strains by crossing a *cdc13-1* mutant able to grow at 36°C, with a *cdc13-1* strain and confirming that all *cdc13-1 exo1*Δ *pif1*Δ progeny could all grow at 36°C ([Supplementary Figure S1B](#S1){ref-type="supplementary-material"}). We conclude that Pif1 and Exo1 inhibit growth of *cdc13-1* mutants through different pathways, and inactivation of these pathways may eliminate the requirement for telomere capping by Cdc13.

At DSBs, parallel nuclease activities dependent upon Exo1, the helicase Sgs1 and nuclease Dna2 generate extensive ssDNA ([@b26]; [@b41]; [@b74]). We hypothesized that, as with Exo1, elimination of Sgs1 or Dna2 in cells lacking Pif1 might improve the growth of *cdc13-1* mutants and perhaps even permit growth at 36°C. However, we found that *cdc13-1 pif1*Δ *dna2*Δ mutants grew less well than *cdc13-1 pif1*Δ mutants ([Supplementary Figure S2A](#S1){ref-type="supplementary-material"}). We were unable to examine the effect of *dna2*Δ on the growth of *cdc13-1 PIF1*^+^ mutants, as *DNA2* is an essential gene unless *PIF1* is deleted ([@b9]). We also found that *cdc13-1 pif1*Δ *sgs1*Δ mutants grew slightly less well than *cdc13-1 pif1*Δ mutants and that *cdc13-1 sgs1*Δ mutants grew slightly less well than *cdc13-1* mutants ([Supplementary Figure S2B](#S1){ref-type="supplementary-material"}), consistent with other work from our laboratory ([@b45]). We conclude that Exo1 inhibits the growth of *cdc13-1* mutants with uncapped telomeres, whereas Sgs1 and Dna2 contribute to the vitality of such cells. Therefore, we chose to focus on the roles of Pif1 and Exo1 at uncapped telomeres.

Elimination of Pif1 and Exo1 permits telomere maintenance following inactivation of Cdc13
-----------------------------------------------------------------------------------------

Yeast cells can overcome the requirement for Cdc13 by altering telomere structure, as observed in rare variants, which can be selected for after inactivation of telomerase or after attenuation of nuclease/checkpoint activities at uncapped telomeres ([@b30]; [@b76]). To test whether elimination of Pif1 and Exo1 caused alterations in telomere structure that could explain the growth of *cdc13-1* cells at 36°C, we performed Southern blots to examine telomere structure, probing for Y′ sequences ([Figure 2B](#f2){ref-type="fig"}), which are components of the majority of yeast telomeres ([Supplementary Figure S3A and B](#S1){ref-type="supplementary-material"}). The Y′ probe contained G-rich sequences and weakly cross-hybridized to telomeres that did not contain Y′ sequences, so we also probed for TG repeat sequences to detect telomeres that lacked Y′ elements ([Supplementary Figure S4](#S1){ref-type="supplementary-material"}).

*pif1*Δ mutants have long telomeres ([@b55]) and consistent with this, *CDC13*^+^*exo1*Δ *pif1*Δ mutants have longer telomeres than *CDC13*^+^*EXO1*^+^*PIF1*^+^ strains (compare lanes 1--2, 3--4 and 7--8; [Figure 2B](#f2){ref-type="fig"}). The telomeres of *cdc13-1 exo1*Δ *pif1*Δ mutants grown at 36°C were longer than those of *CDC13*^+^*exo1*Δ *pif1*Δ mutants grown at 23°C (compare lanes 9--10 with lanes 7--8, [Figure 2B](#f2){ref-type="fig"}) but indistinguishable from those of *cdc13-1 exo1*Δ *pif1*Δ mutants grown at 23°C (compare lanes 9--10 with lanes 17--18, [Figure 2B](#f2){ref-type="fig"}). This demonstrates that no gross alterations in telomere structure occur when *cdc13-1 exo1*Δ *pif1*Δ mutants are grown at 36°C. Furthermore, *cdc13-1 exo1*Δ *pif1*Δ mutants are able to grow at 36°C, whereas *cdc13-1 pif1*Δ mutants are not, but are indistinguishable in telomere structure (compare lanes 13--14 with lanes 17--18, [Figure 2B](#f2){ref-type="fig"}). We conclude that alterations in telomere structure most likely do not account for the growth of *cdc13-1 exo1*Δ *pif1*Δ mutants at 36°C.

Pif1 exists as both nuclear and mitochondrial isoforms ([@b55]). Therefore, we wanted to know whether the nuclear or mitochondrial function of Pif1 inhibited growth of *cdc13-1 exo1*Δ mutants at 36°C. The *pif1-m2* allele, lacking nuclear Pif1, permitted growth of *cdc13-1 exo1*Δ mutants at 36°C, whereas the *pif1-m1* allele, lacking mitochondrial Pif1, did not ([Figure 2C](#f2){ref-type="fig"}). We note that the growth of *cdc13-1 exo1*Δ *pif1-m2* mutants at 36°C is less than *cdc13-1 exo1*Δ *pif1*Δ mutants ([Figure 2C](#f2){ref-type="fig"}). This is consistent with other reports that low levels of nuclear Pif1 activity persist in *pif1-m2* mutants ([@b55]; [@b52]). We also confirmed that helicase activity of Pif1 inhibited growth of *cdc13-1 exo1*Δ mutants because the *pif1-hd* allele, deficient in helicase activity, also permitted growth at 36°C ([Figure 2C](#f2){ref-type="fig"}) ([@b73]; [@b52]). We conclude that nuclear, helicase-dependent activity of Pif1 inhibits growth of telomere capping-defective *cdc13-1* mutants.

Pif1- and Exo1-dependent nucleases initiate the DDR following Cdc13 inactivation
--------------------------------------------------------------------------------

Upon Cdc13 inactivation, nuclease activities generate ssDNA, which stimulates checkpoint kinase cascades and induces metaphase arrest ([Figure 1A](#f1){ref-type="fig"}) ([@b22]). To test the role of Pif1 in cell cycle arrest, *cdc13-1* mutants were synchronized in G1 using α factor at 23°C, then released to 36°C to assess metaphase arrest ([Figure 3A](#f3){ref-type="fig"}). All strains also harboured the *cdc15-2* mutation so that any cells that overcame *cdc13-1*-induced metaphase arrest would arrest in late anaphase due to *cdc15-2* and be unable to enter another cell cycle ([Figure 3A](#f3){ref-type="fig"}) ([@b34]; [@b75]). As expected, *cdc13-1* mutants accumulated at metaphase and did not pass through to anaphase ([Figure 3B and C](#f3){ref-type="fig"}). *cdc13-1 exo1*Δ mutants accumulated at metaphase with similar kinetics to *cdc13-1* mutants but, as previously reported, a subpopulation of *cdc13-1 exo1*Δ cells escaped metaphase arrest and accumulated in late anaphase due to the *cdc15-2* mutation ([Figure 3B and C](#f3){ref-type="fig"}) ([@b75]). *cdc13-1 pif1*Δ mutants behaved like *cdc13-1* mutants and did not pass through to anaphase ([Figure 3B and C](#f3){ref-type="fig"}). Interestingly, *cdc13-1 exo1*Δ *pif1*Δ mutants did not accumulate in metaphase at all and passed readily through to anaphase ([Figure 3B and C](#f3){ref-type="fig"}). Taken together, these results show that Pif1 has no effect on metaphase arrest of *cdc13-1* mutants at 36°C when Exo1 is present, but it is responsible for the arrest of a subpopulation of cells when Exo1 is absent.

Following inactivation of Cdc13, Mec1-dependent checkpoint activation occurs, leading to activation and hyperphosphorylaiton of the kinase Rad53 ([Figure 1A](#f1){ref-type="fig"}) ([@b60]; [@b44]). We used the synchronous cultures to examine Rad53 phosphorylation by western blot ([Figure 3A](#f3){ref-type="fig"}). *cdc13-1* and *cdc13-1 pif1*Δ mutants exhibited strong Rad53 phosphorylation, indicated by a marked upward mobility shift of Rad53 (upper panels, [Figure 3D](#f3){ref-type="fig"}). A reduction in Rad53 phosphorylation was seen in *cdc13-1 exo1*Δ mutants, correlating with the recovery from metaphase arrest displayed by *cdc13-1 exo1*Δ mutants following telomere uncapping ([Figure 3C and D](#f3){ref-type="fig"}). Interestingly, no discernable change in the mobility of Rad53 could be seen in *cdc13-1 exo1*Δ *pif1*Δ mutants, consistent with their complete failure to arrest cell division at 36°C ([Figure 3C and D](#f3){ref-type="fig"}). We conclude that in the absence of Pif1 and Exo1, the checkpoint kinase Rad53 is not activated after telomere uncapping in *cdc13-1* mutants.

To see whether *cdc13-1 exo1*Δ *pif1*Δ strains were defective in the DDR after other types of DNA damage as well as after telomere uncapping, we treated cells with bleomycin to induce DSBs. At both DSBs and uncapped telomeres, ssDNA is an important stimulus for the Mec1-dependent checkpoint. We treated the same set of strains examined in [Figure 3B--D](#f3){ref-type="fig"}, with bleomycin at 23°C after release from G1 arrest. *cdc13-1*, *cdc13-1 pif1*Δ, *cdc13-1 exo1*Δ and *cdc13-1 exo1*Δ *pif1*Δ mutants all behaved similarly, phosphorylating Rad53 and arresting at methaphase ([Figure 3E](#f3){ref-type="fig"}; [Supplementary Figure S4](#S1){ref-type="supplementary-material"}). We conclude that a functional DDR pathway operates in (*cdc13-1*) *exo1*Δ *pif1*Δ cells but that these cells are specifically defective in responding to telomere uncapping.

Telomeric ssDNA stimulates metaphase arrest following telomere uncapping ([@b22]). We used synchronous cultures ([Figure 3A](#f3){ref-type="fig"}) and quantitative amplification of ssDNA (QAOS) to measure subtelomeric ssDNA in repetitive Y′ elements (present on Chromosome V and most other chromosome ends) following Cdc13 inactivation ([Figure 4A](#f4){ref-type="fig"}) ([@b7]). c*dc13-1* mutants with uncapped telomeres generated ssDNA at both the Y′600 and Y′5000 loci ([Figure 4B and C](#f4){ref-type="fig"}). *cdc13-1 exo1*Δ mutants generated less ssDNA following telomere uncapping at the Y′ loci, as previously reported ([@b38]; [@b75]). Interestingly, *cdc13-1 pif1*Δ mutants, like *cdc13-1 exo1*Δ mutants showed reduced ssDNA generation in the Y′600 and Y′5000 loci following telomere uncapping. Furthermore, *cdc13-1 exo1*Δ *pif1*Δ mutants generated no detectable ssDNA at Y′600 or Y′5000 loci following telomere uncapping ([Figure 4B and C](#f4){ref-type="fig"}). We confirmed that ssDNA generation occurred on the TG (3′) strand due to degradation of the AC (5′) strand, as we were unable to detect ssDNA on the AC strand ([Figure 4D](#f4){ref-type="fig"}). We conclude that Pif1, like Exo1, is important for ssDNA generation after telomere uncapping in *cdc13-1* mutants and appears to regulate a nuclease activity, which functions in parallel to Exo1 at chromosome ends.

To examine how Pif1 and Exo1 affect ssDNA accumulation further from chromosome ends, we measured ssDNA at single-copy loci on Chromosome V after Cdc13 inactivation. At 4 h, *cdc13-1* mutants generated ssDNA at all loci examined, with the amount of ssDNA decreasing at loci further from the chromosome end, as previously reported ([@b75]). *cdc13-1 exo1*Δ mutants generated less ssDNA in the Y′ repeats and no ssDNA in single-copy loci on Chromosome V, also as previously reported ([Figure 4E](#f4){ref-type="fig"}) ([@b75]). *cdc13-1 pif1*Δ mutants generated similar amounts of ssDNA to *cdc13-1 exo1*Δ mutants in the Y′ repeats. However, at more distal, single-copy loci, *cdc13-1 pif1*Δ mutants generated less ssDNA than *cdc13-1* mutants but more than *exo1*Δ *cdc13-1* mutants. The higher levels of ssDNA generated further from the chromosome end in *cdc13-1 pif1*Δ mutants, in comparison with *cdc13-1 exo1*Δ mutants, most likely accounts for their sustained metaphase arrest following telomere uncapping ([Figure 3B and C](#f3){ref-type="fig"}). Furthermore, the ssDNA generated by *cdc13-1* and *cdc13-1 pif1*Δ mutants \<10 kb from the chromosome end is \>1.6% (1/64) ([Figure 4E](#f4){ref-type="fig"}). Assuming 1 single-stranded telomere per cell is sufficient to stimulate arrest, this suggests that ssDNA extending \<10 kb on one of the 64 G2 telomeres in *Saccharomyces cerevisiae* is sufficient to stimulate metaphase arrest ([Figure 4E](#f4){ref-type="fig"}) ([@b53]; [@b66]; [@b75]).

No checkpoint activation was detected in *cdc13-1 exo1*Δ *pif1*Δ mutants following telomere uncapping, and no ssDNA was detected in the Y′ elements ([Figures 3D](#f3){ref-type="fig"} and [4B](#f4){ref-type="fig"}). However, *yku70*Δ mutants at 23°C have detectable ssDNA in the telomeric TG repeats but do not undergo checkpoint activation ([@b27]; [@b50]; [@b38]). Thus, we hypothesized that *cdc13-1 exo1*Δ *pif1*Δ mutants might still generate detectable ssDNA in the TG repeats. We used synchronous cultures ([Figure 3A](#f3){ref-type="fig"}) and measured ssDNA by in-gel assay to measure ssDNA in the TG repeats in *cdc13-1* mutants ([Figure 4F and G](#f4){ref-type="fig"}). *cdc13-1* mutants generated large amounts of TG ssDNA at 2 and 4 h following telomere uncapping ([Figure 4F](#f4){ref-type="fig"}), corresponding to an approximately five-fold increase in signal compared with *yku70*Δ mutants ([Figure 4G](#f4){ref-type="fig"}). *cdc13-1 exo1*Δ *pif1*Δ mutants also generated detectable ssDNA 2 h following telomere uncapping, but at a level approximately equal to that of a *yku70*Δ mutant ([Figure 4F and G](#f4){ref-type="fig"}). However, the ssDNA generated in *cdc13-1 exo1*Δ *pif1*Δ mutants was transient and was no longer detectable 4 h after telomere uncapping ([Figure 4F and G](#f4){ref-type="fig"}). Surprisingly, *cdc13-1 pif1*Δ mutants displayed only a modest decrease in ssDNA generation in the TG repeats following telomere uncapping, whereas *cdc13-1 exo1*Δ mutants generated very little ssDNA ([Figure 4F and G](#f4){ref-type="fig"}). We conclude that *cdc13-1 exo1*Δ *pif1*Δ mutants generate limited, transient ssDNA that is insufficient to stimulate checkpoint activation and that Exo1 is much more important than Pif1 for ssDNA generation in the TG repeats following telomere uncapping.

Pif1 has important functions in cells lacking telomerase
--------------------------------------------------------

It has been suggested that increased levels of telomerase at the telomeres of *cdc13-1 pif1*Δ cells shields uncapped telomeres from nuclease activities ([@b67]). However, this is somewhat inconsistent with our observation that Pif1 has relatively little effect on ssDNA generation in the telomeric TG repeats, where telomerase presumably binds ([Figure 4G](#f4){ref-type="fig"}). Therefore, we wanted to know whether the ability of the *pif1*Δ mutation to improve the growth of *cdc13-1* mutants was dependent upon the telomerase template component (TLC1) or catalytic subunit (Est2). Interestingly, we found that *cdc13-1 tlc1*Δ *pif1*Δ and *cdc13-1 tlc1*Δ *exo1*Δ mutants grew better at 25°C than *cdc13-1 tlc1*Δ mutants (compare rows 7--8 and 11--12 with 3--4, [Figure 5A](#f5){ref-type="fig"}; [Supplementary Figure S6](#S1){ref-type="supplementary-material"}). We also found that *cdc13-1 est2*Δ *pif1*Δ and *cdc13-1 est2*Δ *exo1*Δ mutants were able to grow at 25°C, whereas *cdc13-1 est2*Δ mutants were not ([Supplementary Figure S7](#S1){ref-type="supplementary-material"}). We conclude that Pif1 has a telomerase (TLC1, Est2) independent effect at uncapped telomeres. However, we note that *est2*Δ *cdc13-1* and *tlc1*Δ *cdc13-1* mutants grow worse than *cdc13-1* mutants, demonstrating that telomerase contributes to telomere capping following inactivation of Cdc13.

Pif1 is responsible for the residual checkpoint activation in *cdc13-1 exo1*Δ mutants ([Figure 3D](#f3){ref-type="fig"}) and inhibits growth of *cdc13-1* mutants lacking telomerase ([Figure 5A](#f5){ref-type="fig"}). We hypothesized that Pif1 would contribute to ssDNA generation at uncapped telomeres and subsequent checkpoint activation, even in *cdc13-1* mutants lacking telomerase. To test this, we measured Rad53 phosphorylation ([Supplementary Figure S8A](#S1){ref-type="supplementary-material"}) and telomeric TG repeat ssDNA ([Supplementary Figure S8B and C](#S1){ref-type="supplementary-material"}) in *cdc13-1* and *cdc13-1 tlc1*Δ mutants, before and after telomere uncapping. In *cdc13-1 tlc1*Δ *exo1*Δ *pif1*Δ mutants, there was a decrease in Rad53 phosphorylation compared with *cdc13-1 tlc1*Δ *exo1*Δ mutants ([Supplementary Figure S8A](#S1){ref-type="supplementary-material"}). We also found that *cdc13-1 tlc1*Δ *pif1*Δ and *cdc13-1 tlc1*Δ *exo1*Δ *pif1*Δ mutants generated less ssDNA than *cdc13-1 tlc1*Δ and *cdc13-1 tlc1*Δ *exo1*Δ mutants, respectively, following telomere uncapping ([Supplementary Figure S8B and C](#S1){ref-type="supplementary-material"}). We conclude that Pif1 has a contribution to ssDNA generation and checkpoint activation following telomere uncapping that is independent of telomerase. However, we note that 40% of *cdc13-1 tlc1*Δ cells were at metaphase at 23°C compared with 30% of *cdc13-1 tlc1*Δ *pif1*Δ cells ([Supplementary Figure S8D](#S1){ref-type="supplementary-material"}). Thus, we cannot exclude the possibility that reduced ssDNA generation in *cdc13-1 tlc1*Δ *pif1*Δ mutants is due to altered kinetics of accumulation at metaphase.

Although Pif1 clearly demonstrates a telomerase-independent effect in *cdc13-1* mutants, we note that *cdc13-1 tlc1*Δ *exo1*Δ mutants could grow at 27°C, whereas *cdc13-1 tlc1*Δ *pif1*Δ mutants could not (compare rows 11--12 with 7--8, [Figure 5A](#f5){ref-type="fig"}). In contrast, *cdc13-1 TLC1*^+^*exo1*Δ mutants and *cdc13-1 TLC1*^+^*pif1*Δ mutants could both grow similarly at 27°C (compare rows 9--10 with 5--6, [Figure 5A](#f5){ref-type="fig"}). This shows that Pif1 is less potent than Exo1 at inhibiting growth of *cdc13-1 tlc1*Δ mutants than *cdc13-1 TLC1*^+^ mutants.

To help clarify the role of Pif1 in *cdc13-1 tlc1*Δ and *cdc13-1 TLC1*^+^ mutants, we examined the effect of Pif1 in *CDC13*^+^ *tlc1*Δ mutants. Yeast strains that cannot recruit telomerase (e.g. *tlc1*Δ) lose telomeric DNA with each cell division until the cultures senesce and lose proliferative capacity, much like mammalian fibroblasts. Senescent, telomerase-deficient yeast cultures usually recover, using telomerase-independent, recombination-dependent mechanisms of telomere maintenance, leading to clear changes in telomere structure ([@b32]; [@b61]). Therefore, we germinated spores containing combinations of null mutations in telomerase (*TLC1*), *PIF1* and *EXO1*, and assessed growth at various passages ([Figure 5B](#f5){ref-type="fig"}). As expected, *tlc1*Δ mutants grew well at passage 1, poorly from passages 2--5 (senescence) and grew well again from passage 7 (recovery) ([Figure 5B](#f5){ref-type="fig"}). *tlc1*Δ *exo1*Δ mutants showed a similar pattern of growth to *tlc1*Δ mutants but grew slightly better prior to senescence, as previously reported (passages 3 and 4, [Figure 5B](#f5){ref-type="fig"}) ([@b39]). In contrast, *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ strains showed a rapid decline in growth from passages 2--6 (senescence) and exhibited a protracted senescence period but slowly recovered by passage 15 ([Figure 5B](#f5){ref-type="fig"}). We conclude that Pif1 inhibits entry into senescence and promotes recovery. Taken with the data discussed earlier, Pif1 contributes to good growth of *tlc1*Δ mutants from passage 2 onwards, yet inhibits growth of *cdc13-1* mutants ([Figures 1C](#f1){ref-type="fig"} and [5A](#f5){ref-type="fig"}). In contrast, Exo1 has only a small effect on the growth of *tlc1*Δ mutants, yet inhibits growth of *cdc13-1* mutants ([Figures 1C](#f1){ref-type="fig"} and [5A](#f5){ref-type="fig"}). Thus, it is likely that the relatively poor growth of *cdc13-1 tlc1*Δ *pif1*Δ compared with *cdc13-1 tlc1*Δ *exo1*Δ mutants is due to the poor growth of *tlc1*Δ *pif1*Δ mutants compared with *tlc1*Δ *exo1*Δ mutants.

After long cultivation (passage 15, 45 days growth) *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ mutants could be distinguished from those of *tlc1*Δ and *tlc1*Δ *exo1*Δ mutants by their poor growth ([Figure 5B](#f5){ref-type="fig"}). Telomerase-deficient survivors typically show clear alterations in telomere structure---type I survivors undergo dramatic amplification of Y′ elements and retain short TG overhangs, whereas type II survivors show modest amplification of Y′ elements but amplify their TG overhangs ([@b61]). Therefore, we examined the telomeres of *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ mutants. At passage 1, before entry into senescence, *tlc1*Δ, *tlc1*Δ *exo1*Δ, *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ mutants all had short telomeres (compare lanes 1--4 with lanes 5--12, [Figure 5C](#f5){ref-type="fig"}). At passage 15, *tlc1*Δ mutants and *tlc1*Δ *exo1*Δ mutants had amplified Y′ elements and terminal fragments to generate type II (lanes 17--18, [Figure 5D](#f5){ref-type="fig"}) or type I (lanes 21--22, [Figure 5D](#f5){ref-type="fig"}) survivors. In contrast, *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ mutants at passage 15 had shorter telomeres than at passage 1 and had undergone a reduction in Y′ elements, but did not appear to have generated type I or type II survivor telomere structures (compare lanes 7--8 with 19--20 and lanes 11--12 with 23--24, [Figure 5D](#f5){ref-type="fig"}). We noted that *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ mutants resembled type I survivors in that our TG probe did not detect any individual telomeres further up the gel (marked with arrows, compare lanes 7--8 with 19--20 and lanes 11--12 with 23--24, [Supplementary Figure S10](#S1){ref-type="supplementary-material"}), indicating that all telomeres in these strains had acquired a terminal Y′ fragment. However, the terminal fragments of *tlc1*Δ *pif1*Δ and *tlc1*Δ *pif1*Δ *exo1*Δ were even shorter than those of type I survivors and they had undergone a reduction, not an amplification in Y′ elements, clearly distinguishing them from typical type I survivors (compares lanes 19--20, 23--24 with lanes 21--22, [Figure 5D](#f5){ref-type="fig"}). We conclude that Pif1 is required for the generation of type I and type II survivors and that in the absence of Pif1, cells lacking telomerase can improve growth following senescence without adopting typical type I or type II survivor structures.

Telomerase is crucial for survival in the absence of Cdc13
----------------------------------------------------------

Cdc13 has two crucial functions at telomeres---one, to shield telomeres from nuclease activities and the second to recruit telomerase to the telomere ([@b46]). Although elimination of Pif1 and Exo1 permits *cdc13-1* mutants to grow at 36°C (presumably when *cdc13-1* is completely inactivated), this does not permit *cdc13-1 tlc1*Δ mutants to grow at 36°C (compare rows 13--14 with 15--16, [Figure 5A](#f5){ref-type="fig"}), demonstrating that telomerase has a function in *cdc13-1* mutants at 36°C. Therefore, we hypothesized that at 36°C, Cdc13-1 might retain the ability to recruit telomerase, and Cdc13-dependent telomerase activity might be essential for growth. Alternatively, telomerase might be recruited to telomeres in a Cdc13-independent manner.

To test whether Cdc13-1 retained the ability to recruit telomerase in *cdc13-1 exo1*Δ *pif1*Δ cells at 36°C, we decided to delete *CDC13*. We generated diploid strains heterozygous for *pif1*Δ, *exo1*Δ and *cdc13*Δ mutations. Diploids were sporulated, tetrads dissected and vegetative cells containing combinations of the three deletion mutations were allowed to form colonies. [Figure 6A](#f6){ref-type="fig"} shows a representative image of one tetrad dissection plate. Importantly, we found that *cdc13*Δ *exo1*Δ *pif1*Δ strains were viable and had a germination efficiency of ∼90% compared with *CDC13 exo1*Δ *pif1*Δ strains ([Figure 6A](#f6){ref-type="fig"}; [Supplementary Table SI](#S1){ref-type="supplementary-material"}). However, it was clear that *cdc13*Δ *exo1*Δ *pif1*Δ mutants grew less well than *CDC13*^+^*exo1*Δ *pif1*Δ mutants on the tetrad dissection plates ([Figure 6A](#f6){ref-type="fig"}). No viable colonies were formed from *cdc13*Δ cells that were either *PIF1*^+^ or *EXO1*^+^. We conclude that neither Cdc13-dependent telomerase activity nor Cdc13-dependent capping activities are required for growth following elimination of Pif1 and Exo1.

The viability of *cdc13*Δ *exo1*Δ *pif1*Δ strains was surprising in the light of the requirement for telomerase in *cdc13-1 exo1*Δ *pif1*Δ strains. We hypothesized that Cdc13-independent telomerase activity was essential for the viability of *cdc13*Δ *exo1*Δ *pif1*Δ strains. To test this, we generated diploid strains heterozygous for *pif1*Δ, *exo1*Δ, *cdc13*Δ and *tlc1*Δ mutations, containing a plasmid that carried a wild-type copy of *CDC13*. Diploids were sporulated and tetrad dissection was performed to generate strains containing combinations of the four deletion mutations, in addition to the wild-type copy of *CDC13*. These strains were diluted across agar plates either fully supplemented (YEPD), lacking uracil (−URA) or containing FOA (FOA). FOA is toxic to cells with an active uracil biosynthetic pathway so only cells able to survive in the absence of the *URA3-* and *CDC13-*containing plasmid would be able to grow. As expected, *cdc13*Δ *TLC1*^+^ and *cdc13*Δ *tlc1*Δ mutants were able to grow on YEPD and --URA, but not on FOA medium, demonstrating that *CDC13* was essential for survival of these cell types ([Figure 6B](#f6){ref-type="fig"}). *cdc13*Δ *TLC1*^+^*exo1*Δ *pif1*Δ strains were able to grow on FOA, YEPD and --URA, demonstrating that *CDC13* was not essential in this background ([Figure 6B](#f6){ref-type="fig"}). However, *cdc13*Δ *TLC1*^+^*exo1*Δ *pif1*Δ cells grew much more poorly on FOA than on --URA and YEPD consistent the poor growth of *cdc13*Δ *exo1*Δ *pif1*Δ cells on the tetrad dissection plate(s) ([Figure 6A](#f6){ref-type="fig"}). Importantly, *cdc13*Δ *tlc1*Δ *exo1*Δ *pif1*Δ cells were able to grow on YEPD and --URA but not on FOA, demonstrating that they could not survive in the absence of Cdc13. We conclude that telomerase is essential for the survival of *cdc13*Δ *exo1*Δ *pif1*Δ mutants, suggesting that Cdc13-independent recruitment of telomerase is essential for their survival.

We used the same plasmid-based method to assess the requirement for various proteins involved in telomere maintenance to the growth of *cdc13*Δ *exo1*Δ *pif1*Δ mutants. We confirmed that TLC1 was required for the viability of *cdc13*Δ *pif1*Δ *exo1*Δ as *cdc13*Δ *pif1*Δ *exo1*Δ *tlc1*Δ mutants could not lose a plasmid carrying *CDC13* (*p\[URA3\]CDC13*) ([Figure 6C](#f6){ref-type="fig"}). We also found that Yku70 (a component of the Ku complex, which binds TLC1 to aid in recruitment of telomerase to the telomere) and Rad52 (required for homologous recombination and the generation of type I and type II survivor telomere structures) were required for the viability of *cdc13*Δ *pif1*Δ *exo1*Δ mutants ([Figure 6C](#f6){ref-type="fig"}). However, we found that Pol32 (subunit of Polymerase δ, required for the generation of type I and type II survivor telomere structures) was dispensable for the viability of *cdc13*Δ *pif1*Δ *exo1*Δ mutants ([Figure 6C](#f6){ref-type="fig"}), although elimination of Pol32 did reduce the frequency at which *cdc13*Δ *pif1*Δ *exo1*Δ mutants were able to lose the *pURA3\[CDC13\]* ([Supplementary Figure S12](#S1){ref-type="supplementary-material"}). We conclude that *cdc13*Δ *pif1*Δ *exo1*Δ mutants are distinct from type I and type II survivors, as they do not require Pol32, and their telomeres are maintained through a combination of homologous recombination, Ku and telomerase activity.

If *cdc13*Δ *exo1*Δ *pif1*Δ mutants are able to recruit telomerase then they may not senesce or undergo the rearrangements in telomere structure characteristic of telomerase-deficient strains. To test this hypothesis, we compared the growth and telomere structure of *cdc13*Δ *exo1*Δ *pif1*Δ strains with *tlc1*Δ and *tlc1*Δ *exo1*Δ *pif1*Δ strains. As expected, telomerase-deficient *tlc1*Δ mutants senesced and recovered ([Figure 7A](#f7){ref-type="fig"}) and by passage 11 they had generated type I (lane 15, [Figure 7B](#f7){ref-type="fig"}) and type II (lane 16, [Figure 7B](#f7){ref-type="fig"}) survivors. Interestingly, *cdc13*Δ *exo1*Δ *pif1*Δ strains showed a slight growth defect at passage 1 ([Figure 7A](#f7){ref-type="fig"}), consistent with the small colonies formed by *cdc13*Δ *exo1*Δ *pif1*Δ mutants on the tetrad dissection plate ([Figure 6A](#f6){ref-type="fig"}) and the growth defect of *cdc13*Δ *TLC1*^+^*exo1*Δ *pif1*Δ *pURA3\[CDC13\]* mutants grown on FOA ([Figure 6B](#f6){ref-type="fig"}). However, by passage 5 and in all subsequent passages *cdc13*Δ *exo1*Δ *pif1*Δ mutants had improved in growth ([Figure 7A](#f7){ref-type="fig"}). The telomeres of *cdc13*Δ *exo1*Δ *pif1*Δ mutants were long with more variation in length, and by passage 11, the median telomere length and variance in length increased (lanes 9--12, 21--24, [Figure 7B](#f7){ref-type="fig"}). This is consistent with previous work showing that hypomorphic alleles of Cdc13 can cause increased telomere length and variance in telomere length ([@b11]). No clear alterations in the telomere structure of *cdc13*Δ *exo1*Δ *pif1*Δ mutants were observed, and at passage 1, their telomeres most closely resembled those of *cdc13-1 exo1*Δ *pif1*Δ mutants with capped telomeres, which notably do not senesce (compare lanes 2, 14 with lanes 9--12, [Figure 7B](#f7){ref-type="fig"}). The growth and telomere structure of *cdc13*Δ *exo1*Δ *pif1*Δ mutants was clearly distinct from that of telomerase-deficient *tlc1*Δ *exo1*Δ *pif1*Δ mutants, which rapidly senesced and slowly recovered ([Figure 7A](#f7){ref-type="fig"}), while maintaining a relatively normal telomere structure (compare lanes 7--8 with lanes 19--20, [Figure 7B](#f7){ref-type="fig"}). We conclude that *cdc13*Δ *exo1*Δ *pif1*Δ mutants do not undergo senescence and maintain their telomeres for at least 11 passages (44 days). This is consistent with our notion that *cdc13*Δ *exo1*Δ *pif1*Δ mutants are able to maintain telomeres in a telomerase-dependent manner, even in the absence of Cdc13.

Finally, although we observed that *cdc13-1 exo1*Δ *pif1*Δ mutants generated ssDNA only in the TG repeats, transiently over the course of a single cell cycle, we wished to know whether repeated cell division in the absence of telomere capping would lead to accumulation of ssDNA. By in-gel assay, we found that *cdc13-1 exo1*Δ *pif1*Δ mutants grown at 36°C for 4 h (∼2 population doublings with uncapped telomeres) and *cdc13*Δ *exo1*Δ *pif1*Δ mutants from Passage 1 (∼50 population doublings with uncapped telomeres) generated comparable levels of ssDNA in the TG repeats to a *yku70*Δ mutant ([Figure 7C and D](#f7){ref-type="fig"}). This was comparable to the transient level of ssDNA seen in *cdc13-1 exo1*Δ *pif1*Δ mutants 2 h after telomere uncapping, within a single cell cycle ([Figure 4G](#f4){ref-type="fig"}). We conclude that continued growth following telomere uncapping in *exo1*Δ *pif1*Δ mutants does not lead to ssDNA accumulation. This suggests that no residual nuclease activities continue to resect uncapped telomeres in the absence of Pif1 and Exo1.

Discussion
==========

We have shown that Pif1 and Exo1 are responsible for extensive ssDNA generation at uncapped telomeres in *cdc13-1* mutants and also that Pif1 has telomerase-independent functions at telomeres. This leads us to propose a model where Pif1 can initiate the DDR at uncapped telomeres by controlling nuclease activity. Furthermore, and remarkably, cells lacking Pif1 and Exo1 are viable and grow well in the absence of the usually essential telomere capping protein Cdc13.

In our model ([Figure 8](#f8){ref-type="fig"}), Pif1 unwinds telomeric duplex DNA, generating ssDNA that is cleaved by an unidentified ssDNA endonuclease in a manner analogous to the function of Pif1 in Okazaki fragment processing and at stalled replication forks ([@b9]; [@b12]; [@b24]; [@b48]). We propose that close to the chromosome end (\<5 kb) both Pif1- and Exo1-dependent activities generate ssDNA, causing weak initial checkpoint activation. We propose that Exo1 subsequently generates ssDNA \>5 kb from the chromosome end, leading to stronger checkpoint activation that is sufficient to arrest all cells with uncapped telomeres. Our model is consistent with Pif1 being ExoY, a hypothetical nuclease proposed to function in parallel to Exo1 at uncapped telomeres ([@b75]). Pif1, like ExoY, is more important for ssDNA generation at the end of the chromosome than further away ([Figure 4E](#f4){ref-type="fig"}).

In our model, Exo1 recognizes the junction between 3′ (TG) ssDNA and duplex DNA, at native telomeric overhangs as previously suggested ([@b38]) or at stalled replication forks ([@b56]). We propose that Pif1 binds and unwinds 5′ (AC) overhangs because Pif1 is a 5′--3′ helicase ([@b29]; [@b73]; [@b48]). If Pif1 does engage telomeric dsDNA and convert it to ssDNA, 5′ (AC) ssDNA presumably exists ([Supplementary Figure S15A](#S1){ref-type="supplementary-material"}). Interestingly, 5′ telomeric ssDNA has been observed both in mammalian cells and in *Caenorhabditis elegans* ([@b14]; [@b51]) and but not so far in *S. cerevisiae*. However, 5′ ssDNA overhangs could in principle occur at stalled replication fork structures ([Supplementary Figure S15B](#S1){ref-type="supplementary-material"}) or Okazaki fragments.

DSBs that can be repaired by homologous recombination and DSB-induced shortened telomeres are processed by nucleases dependent upon Sgs1/Dna2, Exo1 and MRX/Sae2 ([@b26]; [@b74]; [@b42]). Other work recently published from our laboratory demonstrates that Sgs1 also contributes to resection of uncapped telomeres, but elimination of Sgs1 and Exo1 is insufficient to prevent the resection of uncapped telomeres in *cdc13-1* mutants ([@b45]). The work presented here demonstrates that elimination of Pif1 and Exo1 prevents resection of uncapped telomeres in *cdc13-1* mutants. However, at DSBs that can be repaired by homologous recombination or at DSB-induced shortened telomeres, Pif1 has little effect on resection ([@b74]; [@b6]). Interestingly, Pif1 has been shown to have a critical role repair of DSBs where break-induced replication (BIR) is the main repair pathway ([@b13]). A major challenge will be to determine which substrates are exposed at DSBs, shortened telomeres and uncapped telomeres and how nuclease activities are coordinated to process them.

Pif1 contributes to the vitality of cells lacking telomerase, both before and after recovery from senescence ([Figure 5B](#f5){ref-type="fig"}). Interestingly, *pif1*Δ cells improve their growth following senescence without adopting typical survivor-like telomeric DNA structures ([Figure 5C](#f5){ref-type="fig"}). Usually following senescence, survivors are generated by homologous-recombination- and BIR-dependent alterations in telomere structure ([@b61]; [@b35]). If BIR is eliminated, cells lacking telomerase senesce and undergo a complete loss in viability ([@b35]). The relatively unaltered telomere structure and poor growth following senescence in cells lacking Pif1 and telomerase is consistent with the impaired BIR seen in cells lacking Pif1 ([@b13]). Therefore, reduced BIR in *pif1*Δ cells may be sufficient to maintain comparatively normal telomere structure in telomerase-deficient cells but insufficient to permit the typical amplification of Y′ elements or terminal TG repeats seen in survivors. The absence of telomeric repeat amplification could prevent these cells from achieving the high levels of post-senescence growth seen in other telomerase-deficient mutants.

We have demonstrated that attenuation of the DDR at uncapped telomeres, by elimination of Pif1 and Exo1 permits telomere maintenance in a Cdc13-indpendent but telomerase and Ku-dependent manner. This is surprising because Cdc13 is considered crucial for efficient recruitment of telomerase and thus to prevent senescence ([@b46]). We propose that in the absence of Cdc13, Yku80 binds TLC1, the telomerase RNA, to help recruit telomerase to the telomere ([@b47]). The requirement for Rad52 for the survival of *cdc13*Δ *exo1*Δ *pif1*Δ mutants is surprising. It will be interesting to investigate whether telomeric repeats from extremely long telomeres in *cdc13*Δ *exo1*Δ *pif1*Δ mutants ([Figure 7B](#f7){ref-type="fig"}) can be distributed to shorter telomeres by homologous recombination, thus preventing short telomeres from becoming critically short. Finally, it will also be paramount to determine whether the requirement for telomerase in *cdc13*Δ *exo1*Δ *pif1*Δ mutants is a consequence of the increased utilization of telomerase that has been reported at the telomeres of cells lacking Pif1 ([@b8]).

We show that following inactivation of Cdc13 or telomerase, telomeric DNA can be stabilized by elimination of Pif1, eliminating resection of uncapped telomeres in cells lacking Cdc13 or permitting telomere maintenance without the generation of typical type I or type II survivor structures in cells lacking telomerase. As Pif1 and Exo1 are conserved from yeast, to mice, to humans, Pif1 might also contribute to the premature mortality caused by telomere dysfunction in telomerase knockout mice ([@b29]; [@b28]; [@b70]; [@b40]; [@b57]). *pif1*^−/−^ and *exo1*^−/−^ mice have previously been examined ([@b70]; [@b57]), and it might be interesting to combine these mutations in a telomerase knockout background to investigate the consequences of telomere dysfunction in *pif1*^−/−^ *exo1*^−/−^ mice, as EXO1 contributes to the telomere dysfunction and premature mortality seen in telomerase knockout mice ([@b54]).

Materials and methods
=====================

Bioinformatics/analysis
-----------------------

A genetic interaction network was created in Cytoscape using *S. cerevisiae* genetic interactions from BioGRID (v2.0.53) ([@b58]; [@b15]). Genes that had genetic interactions with *EXO1* were identified (first neighbours of *EXO1*). A ranked list of all known genes was created, according to how many of the first neighbours of *EXO1* they had a genetic interaction with. The top 10% of this ranked list were then shown. Nodes for each gene were coloured according to whether the genes affected *cdc13-1* growth defects or telomere length ([@b2]; [@b75]; [@b19]; [@b23]; [@b62]; [@b1]; [@b64]).

Yeast strains
-------------

All strains used in this study are *RAD5*^+^ and in the W303 genetic background (Strain Table, [Supplementary data](#S1){ref-type="supplementary-material"}). Standard genetic procedures of transformation and tetrad analysis were used. New gene deletions were constructed by transforming a diploid with PCR-based deletion modules ([@b25]). Point mutations were generated integrated into the genome as described ([@b55]; [@b52]).

Yeast growth assays
-------------------

Growth assays were performed as previously described ([@b75]). Pooled colonies were inoculated into 2 ml of YEPD and grown to saturation at 23°C. Five-fold serial dilutions were replicated onto agar plates and grown at a range of temperatures. Plates were photographed using an SPimager (S&P Robotics). Levels were adjusted with Photoshop CS4.

Passage experiments and quantification of growth
------------------------------------------------

To passage cultures, multiple individual colonies were pooled and restruck. Where growth was quantified, unmodified images were analysed with Colonyzer ([@b31]) and the sum of the trimmed greyscale pixel values for all pixels corresponding to spots and colonies of each strain were used as a measure of growth. Growth was then expressed relative to a *TLC1*^+^ or *TLC1*^+^ *CDC13*^+^ strain included on the same plate.

Telomere length detection
-------------------------

Southern hybridization to examine telomere length and structure was performed similarly to previously described ([@b39]). Genomic DNA was extracted, digested with *Xho*I then run overnight on a 1% agarose gel at 1 V/cm. Southern transfer and detection was then performed using DIG-High Prime Labelling and Detection Kit (Roche) as per the manufacturer\'s instructions and visualized on a FUJI LAS4000. Telomeric probes were synthesized using PCR DIG Probe Synthesis Kit (Roche). TG probe was ∼180 bp of TG repeats, whereas Y′ probe was ∼820 bp of Y′ sequence, both amplified from pDL987 (pHT128) ([@b63]) using oligos m933 and m934 or m935 and m936, respectively. *CDC15* probe was synthesized using oligos m1045 and m1046 as previously described ([@b20]).

Synchronous cultures, cell cycle scoring and QAOS
-------------------------------------------------

Experiments to measure cell cycle progression and ssDNA following telomere uncapping were carried out in *bar1*Δ *cdc15-2 cdc13-1* cells and performed as described ([@b77]). Where indicated, cells were treated with Bleomycin at a final concentration of 50 μg/ml ([@b44]).

Rad53 phosphorylation
---------------------

Western blotting to detect Rad53 phosphorylation was performed essentially as described ([@b44]). Antibodies against Rad53 were from Dan Durocher, Toronto. Anti-tubulin antibodies were from Keith Gull, Oxford. Multiple gels were run to process all samples from a single experiment, but were transferred and detected in parallel and imaged simultaneously.

In-gel assay
------------

In-gel assays were performed essentially as previously described ([@b76]) using a Cy5-labelled oligonucleotide (m2188) detected on a GE Healthcare Typhoon Trio imager. Following detection of ssDNA, the gel was subjected to Southern transfer and hybridization to detect *CDC15*. To quantify ssDNA, the fluorescent signal from the 0.7 to 12 kb range on the gel was measured, relative to the intensity of an exponentially dividing *yku70*Δ mutant on the same gel. All values were then normalized relative to the *CDC15* signal as determined by Southern blot.
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![Pif1 and Exo1 inhibit growth of *cdc13-1* mutants. (**A**) Inactivation of Cdc13 by use of the temperature-sensitive allele *cdc13-1* leads to telomere uncapping. Exo1 and additional nuclease(s) generate ssDNA at uncapped telomeres, which is the stimulus for Mec1-dependent checkpoint activation and cell cycle arrest. (**B**) Ranked diagram of genes that share genetic interactions with *EXO1* and are important in the context of telomeres. (Thicker lines mean more shared genetic interactions). (**C**) Strains of the genotypes shown were serially diluted across agar plates and grown at the temperatures indicated for 3 days. In this and other figures, strain numbers (DLYs) are shown adjacent.](emboj2010267f1){#f1}

![Exo1 and nuclear, helicase activity of Pif1 prevent telomere maintenance following inactivation of Cdc13. (**A**) Cartoon of yeast telomeres, indicating the fragments detected by telomere Southern blots using Y′ probe. Arrows represent *Xho*I cut sites. (**B**) Genomic DNA was prepared from two independent *CDC13*^+^ (+) or *cdc13-1* (TS) strains, grown at 23 or 36°C, digested with *Xho*I and Southern blotted to detect telomeric Y′ and terminal fragments. Blots were reprobed to detect *CDC15* as a loading control. Also see [Supplementary Figure S4](#S1){ref-type="supplementary-material"}. (**C**) *cdc13-1 exo1*Δ mutants defective in nuclear Pif1 (*pif1-m2*), mitochondrial Pif1 (*pif1-m1*) or carrying the helicase-deficient allele of Pif1 (*pif1-hd)* were serially diluted across agar plates and grown at the temperatures indicated for 3 days.](emboj2010267f2){#f2}

![Pif1 and Exo1 stimulate cell cycle arrest following inactivation of Cdc13. (**A**) Synchronous culture experiments to examine the effect of Pif1 and Exo1 on cell cycle arrest following telomere uncapping. *cdc15-2 cdc13-1* cells were synchronized in G1 using α-factor then released at 36°C. Cells arrest at metaphase from telomere uncapping (*cdc13-1*) or at anaphase from Cdc15 inactivation (*cdc15-2*). Samples taken at the time points indicated were stained with DAPI and \>100 cells of each genotype scored for cell cycle position ([@b77]). (**B**) Percentage of cells at metaphase. (**C**) Percentage of cells at late anaphase. (**D**) Western blots of Rad53 following shift to 36°C. Upper and lower panels were run in parallel on separate gels, but transferred, detected and imaged simultaneously. (**E**) Western blots of Rad53 following treatment with bleomycin. Corresponding scoring of cells at metaphase and anaphase given as [Supplementary Figure S5](#S1){ref-type="supplementary-material"}.](emboj2010267f3){#f3}

![Pif1 and Exo1 generate ssDNA at uncapped telomeres. (**A**) Physical map of the right telomere of Chromosome V. Synchronous cultures were subjected to telomere uncapping as in [Figure 3A](#f3){ref-type="fig"}, and samples were taken to measure ssDNA. (**B**) TG-strand ssDNA 600 bp from the end of the telomere (Y′600) measured by QAOS. (**C**) TG-strand ssDNA 5000 bp away from the end of the telomere (Y′5000). (**D**) AC-strand ssDNA 600 bp away from the end of the telomere. (**E**) TG-strand ssDNA generated at loci indicated in (**A**), 4 h after telomere uncapping. Dashed line represents 1.56% (1/64), corresponding to the value expected for 1 single-stranded locus per yeast cell in G2. (**F**) TG-strand ssDNA in the telomeric TG repeats detected by in-gel assay, comparing *cdc13-1* mutants (TS) to a *yku70*Δ control. Loading determined by Southern hybridization with a *CDC15* probe. Lanes were run and detected on the same gel and cropped for presentation purposes. (**G**) Quantification of the ssDNA signal in each lane in (**F**). ssDNA is measured in KUs (Ku units). In all, 1 Ku Unit is the ssDNA signal in an asynchronously dividing *yku70*Δ control at 23°C.](emboj2010267f4){#f4}

![Pif1 has telomerase-independent effects at telomeres. (**A**) A *cdc13-1/CDC13*^+^*tlc1*Δ*/TLC1*^+^*exo1*Δ*/EXO1*^+^*pif1*Δ*/PIF1*^+^ diploid (DLY1628 x DLY5324) was sporulated, dissected and germinated at 23°C to generate strains of the indicated genotype at 23°C. These were taken from the germination plate, grown to saturation, then serially diluted across agar plates and grown at the temperatures indicated for 3 days. (**B**) Strains of the genotypes indicated were passaged repeatedly by restreaking at 30°C for 3 days along with *TLC1*^+^ controls. At the passages indicated, strains were assayed for growth, which was then quantified ([Supplementary Figure S9](#S1){ref-type="supplementary-material"}). Growth at each passage is given as a fraction of the growth of the relevant *TLC1*^+^ strain and the mean of two independent strains is shown. (**C**) At passages 1 and 15, strains assayed for growth in (**B**) had genomic DNA isolated and were Southern blotted with Y′ probe, as in [Figure 2B](#f2){ref-type="fig"}. See [Supplementary Figure S10](#S1){ref-type="supplementary-material"} for detection with TG probe.](emboj2010267f5){#f5}

![*cdc13*Δ *exo1*Δ *pif1*Δ cells are viable but depend upon telomerase and homologous recombination for survival. (**A**) *cdc13*Δ*/CDC13 exo1*Δ*/EXO1 pif1*Δ*/PIF1* diploids (DDY341) were dissected. Viable *cdc13*Δ *exo1*Δ *pif1*Δ meiotic progeny are circled. Spores were incubated for 5 days at 23°C before genotypes were determined by replica plating to selective medium. (**B**) Strains of the genotypes indicated, all carrying a p*URA3\[CDC13\]* plasmid (pDL1012) were germinated, grown to saturation, then serially diluted across YEPD, −URA and FOA agar plates. Plates were incubated at 30°C for 4 days, YEPD plate shown after 2 days, −URA plate shown after 3 days and FOA plate shown after 4 days. (**C**) Summary of the roles of various telomere-related genes and their role in the survival of *cdc13*Δ *pif1*Δ *exo1*Δ mutants as assessed in [Supplementary Figures S11 and S12](#S1){ref-type="supplementary-material"}.](emboj2010267f6){#f6}

![Cells lacking Cdc13 maintain telomeres and do not senesce. (**A**) Strains of the genotypes indicated were passaged repeatedly at 23°C for 4 days along with *TLC1*^+^*CDC13*^+^ controls. At the passages indicated, strains were assayed for growth ([Supplementary Figure S13](#S1){ref-type="supplementary-material"}). Growth at each passage is given as a fraction of the growth of the relevant *TLC1*^+^ *CDC13*^+^ strain. The mean of two *tlc1*Δ strains or four *cdc13*Δ strains is shown. (**B**) At passages 1 and 11, strains that were assayed for growth in (**A**) had genomic DNA isolated and were Southern blotted, as in [Figure 2B](#f2){ref-type="fig"}. *PIF1*^+^*EXO1*^+^*CDC13*^+^ and *exo1*Δ *pif1*Δ *cdc13-1* (TS) strains were grown independently. See [Supplementary Figure S14](#S1){ref-type="supplementary-material"} for original blot probed with Y′ and TG probe. (**C**) *CDC13*^+^ (+), *cdc13*Δ (−) and *cdc13-1* (TS) strains of the genotypes indicated were either grown exponentially at 23 or 36°C for 4 h before their DNA was isolated and telomeric TG ssDNA was detected by in-gel assay as in [Figure 4F](#f4){ref-type="fig"}. (**D**) Quantification of ssDNA from the in-gel assay shown in (**C**), as in [Figure 4F](#f4){ref-type="fig"}.](emboj2010267f7){#f7}

![A model for the roles of Pif1 and Exo1 in the DDR at uncapped telomeres. Following telomere uncapping, 5′ and 3′ ssDNA is exposed within 5 kb of the chromosome end, serving as a substrate for resection. 5′ ssDNA is unwound by Pif1 and presumably cleaved by an unidentified ssDNA endonuclease, whereas the junction between 3′ ssDNA and dsDNA is recognized and resected by the exonuclease Exo1. This low-level processing leads to weak checkpoint activation. Resection of 3′ ssDNA overhangs beyond 5 kb requires Exo1. This further processing causes robust checkpoint activation.](emboj2010267f8){#f8}
